Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Stankoff

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2023
[M A Peyronneau, B Kuhnast, D-L Nguyen, et al.
Revue Neurologique|November 14, 2025
Artificial intelligence in presymptomatic neurological diseases: Bridging normal variation and prodromal signaturesT Soulier, N Burgos, R Hassanaly, et al.
Neurology|October 27, 2004
Clinical and neuropathologic variation in neuronal intermediate filament inclusion diseaseN J Cairns, M Grossman, S E Arnold, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2023
[M A Peyronneau, B Kuhnast, D-L Nguyen, et al.
Revue Neurologique|November 14, 2025
Artificial intelligence in presymptomatic neurological diseases: Bridging normal variation and prodromal signaturesT Soulier, N Burgos, R Hassanaly, et al.
Neurology|October 27, 2004
Clinical and neuropathologic variation in neuronal intermediate filament inclusion diseaseN J Cairns, M Grossman, S E Arnold, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 4